Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Including health economic analysis in pilot studies: lessons learned from a cost-utility analysis within the PROSPECTIV pilot study

Journal article

Burns RM. et al, (2017), Global and Regional Health Technology Assessment

The burden of healthcare costs associated with prostate cancer in Ireland

Journal article

Burns RM. et al, (2016), Global and Regional Health Technology Assessment, 4, 0 - 0

Economic burden of non-malignant blood disorders across Europe: a population-based cost study.

Journal article

Luengo-Fernandez R. et al, (2016), Lancet Haematol, 3, e371 - e378

Economic burden of malignant blood disorders across Europe: a population-based cost analysis.

Journal article

Burns R. et al, (2016), Lancet Haematol, 3, e362 - e370

The Burden of Health Care Costs Associated with Prostate Cancer in Ireland.

Conference paper

Burns RM. et al, (2014), Value Health, 17

Challenges in generating costs and utilisation rates associated with castration-resistant prostate cancer.

Journal article

Bourke S. et al, (2014), J Mark Access Health Policy, 2

Factors driving inequality in prostate cancer survival: a population based study.

Journal article

Burns RM. et al, (2014), PLoS One, 9